NCT00526513View on ClinicalTrials.gov

Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL

Enrollment

188

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Diabetes Mellitus

Interventions

DRUG

Insulin Glulisine

subcutaneous injection of insulin glulisine at meal, 1 to 3 injections a day based on the condition of the patient in addition to a basal SC insulin injection at bedtime

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Cairo